{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:04:10Z","timestamp":1788469450335,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.037","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T08:38:20Z","timestamp":1419064700000},"page":"537-547","source":"Crossref","is-referenced-by-count":38,"title":["Neurovascular Protection by Telmisartan via Reducing Neuroinflammation in Stroke-Resistant Spontaneously Hypertensive Rat Brain after Ischemic Stroke"],"prefix":"10.1016","volume":"24","author":[{"given":"Syoichiro","family":"Kono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Omote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Hishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng0697-197","article-title":"Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats","volume":"16","author":"Aitman","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI6691","article-title":"Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension","volume":"103","author":"Pravenec","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib3","first-page":"233","article-title":"Genetic analysis of\u00a0cardiovascular risk factor clustering in spontaneous hypertension","volume":"46","author":"Pravenec","year":"2000","journal-title":"Folia Biol (Praha)"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.33549\/physiolres.930380","article-title":"Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension","volume":"52","author":"Pravenec","year":"2003","journal-title":"Physiol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0047-6374(01)00362-1","article-title":"The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia?","volume":"123","author":"Sabbatini","year":"2003","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)","volume":"36","author":"Schrader","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib10","doi-asserted-by":"crossref","first-page":"H1989","DOI":"10.1152\/ajpheart.00839.2004","article-title":"Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat","volume":"288","author":"Forder","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuropharm.2006.05.029","article-title":"Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress","volume":"51","author":"Hamai","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.CIR.0000138848.58269.80","article-title":"Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation","volume":"110","author":"Iwai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1291\/hypres.31.161","article-title":"Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice","volume":"31","author":"Iwai","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/jpet.108.139618","article-title":"Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study","volume":"326","author":"Kozak","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1291\/hypres.28.307","article-title":"Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients","volume":"28","author":"Suzuki","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib16","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/01.STR.30.11.2391","article-title":"Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats","volume":"30","author":"Dai","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1096\/fj.01-0601com","article-title":"Ischemic injury in experimental stroke depends on angiotensin II","volume":"16","author":"Walther","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib18","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/00004872-200311000-00028","article-title":"Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats","volume":"21","author":"Groth","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00004647-200405000-00008","article-title":"Sustained blockade of\u00a0brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat","volume":"24","author":"Lou","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroscience.2005.03.054","article-title":"Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia","volume":"134","author":"Hosomi","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1096\/fj.04-2960fje","article-title":"Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib22","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/01.hjh.0000249704.34607.4c","article-title":"Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil","volume":"24","author":"Faure","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","volume":"7","author":"Diener","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3565(24)29352-6","article-title":"AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats","volume":"298","author":"Gohlke","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1124\/jpet.102.036772","article-title":"In\u00a0vitro and in\u00a0vivo characterization of the activity of telmisartan: an\u00a0insurmountable angiotensin II receptor antagonist","volume":"302","author":"Maillard","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib26","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib27","doi-asserted-by":"crossref","first-page":"37731","DOI":"10.1074\/jbc.R100034200","article-title":"PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth","volume":"276","author":"Rosen","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.nutr.22.010402.102808","article-title":"PPAR(gamma) and glucose homeostasis","volume":"22","author":"Picard","year":"2002","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbrc.2008.08.032","article-title":"Telmisartan prevented cognitive decline partly due to PPAR-gamma activation","volume":"375","author":"Mogi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/HYPERTENSIONAHA.109.136879","article-title":"Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation","volume":"54","author":"Tsukuda","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.STR.20.8.1037","article-title":"Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion","volume":"20","author":"Nagasawa","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.expneurol.2007.11.028","article-title":"Protective effects of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure","volume":"210","author":"Kumai","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3317\/jraas.2001.013","article-title":"Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats","volume":"2","author":"Wienen","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib34","first-page":"339","article-title":"Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression","volume":"147","author":"Augustin","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib35","article-title":"Long-term Effect of\u00a0Telmisartan on Alzheimer's Amyloid Genesis in SHR-SR After tMCAO","author":"Kurata","year":"2014","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib36","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1042\/BST0341366","article-title":"A new approach for the investigation of reperfusion-related brain injury","volume":"34","author":"Maier","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/jcbfm.2008.164","article-title":"Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain","volume":"29","author":"Yamashita","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.brainres.2010.10.002","article-title":"Lentivirus-mediated transfer of MMP-9 shRNA provides neuroprotection following focal ischemic brain injury in rats","volume":"1367","author":"Hu","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib39","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/01.WCB.0000122747.72175.47","article-title":"Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation","volume":"24","author":"Lee","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/156720210793180747","article-title":"Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage","volume":"7","author":"Lukic-Panin","year":"2010","journal-title":"Curr Neurovasc Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib42","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.fjc.0000140205.74180.3c","article-title":"Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis","volume":"44","author":"Chen","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbrc.2004.12.152","article-title":"Angiotensin II induces MMP-2 in a p47phox-dependent manner","volume":"328","author":"Luchtefeld","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib44","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/01.CIR.0000121735.52471.AC","article-title":"Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity","volume":"109","author":"Cipollone","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib45","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jcpe.12160","article-title":"Effect of telmisartan on levels of IL-1, TNF-\u03b1, down-regulated COX-2, MMP-2, MMP-9 and RANKL\/RANK in an experimental periodontitis model","volume":"40","author":"Ara\u00fajo","year":"2013","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.09.037_bib48","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305714004984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305714004984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:42:59Z","timestamp":1747240979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305714004984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1052305714004984"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.09.037","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}